Evolution and Ecology of Drug Resistance

Figure 1: Relative transmission of drug-resistant strains of M. tuberculosis compared to drug-susceptible strains (adapted from Borrell et al. IJTLD 2009).

What is the Origin of Drug Resistance?

One of the most important questions in the epidemiology of drug-resistant TB is whether the global burden of drug resistance is primarily due to the de novo acquisition of resistance during patient treatment or a consequence of transmission of already drug-resistant strains.

Heterogenity in Transmission

Traditionally, the thought was that drug resistance in bacteria was universally associated with a reduction in virulence and/or transmissibility. However, when reviewing the current evidence for the transmissibility of drug-resistant Mtb, we found that multidrug-resistant strains of Mtb were everything from 10 times less- to 10 times more transmissible than drug-susceptible strains (Figure 1).

Compensatory Mutations

The reason for this heterogeneity is partially because the molecular basis of drug resistance in Mtb is complex, and different drug resistance-conferring mutations are associated with different effects on strain fitness. Moreover, by using a combination of experimental evolution, molecular epidemiology and comparative genome sequencing of clinical strains, we identified compensatory mutations in the RNA polymerase which mitigate some of the negative effects associated with rifampicin resistance in Mtb (Figure 2).

These compensatory mutations were associated with increased fitness in vitro and were overrepresented in regions with high burden of multidrug-resistant TB, illustrating some of the bacterial factors that could lead to the observed heterogeneity in transmission of drug-resistant Mtb.

Figure 2: Compensatory mutations in the RNA polymerase of rifampicin-resistant Mtb (adapted from Comas et al. Nat Genet 2012).

Abdul-wahid Habib A.M. Malaria treatment adherence in the context of reactive case detection in Zanzibar. Basel: Swiss Tropical and Public Health Institute, 2018. MSc

AbouZahr C et al. How can we accelerate progress on civil registration and vital statistics?. Bull World Health Organ. 2018;96(4):226-226A. DOI: 10.2471/BLT.18.211086

Accordini S et al. A three-generation study on the association of tobacco smoking with asthma. Int J Epidemiol. 2018(in press). (ALEC). DOI: 10.1093/ije/dyy031

Akama T et al. Identification of a 4-fluorobenzyl L-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT). Bioorg Med Chem Lett. 2018;28(1):6-10. DOI: 10.1016/j.bmcl.2017.11.028

Ali F.N. Systematic review of tuberculosis control in Ethiopia with special emphasis on pastoralists: adaptation of DOTS for mobile pastoralists. Basel: Swiss Tropical and Public Health Institute, 2018. MIH

Aljeesh Y.I, Alkhaldi M. Institutionalising community health programmes into the Palestinian health-care system: a qualitative study. Lancet, 2018;391:S36. DOI: 10.1016/s0140-6736(18)30361-1

AlKhaldi M, Abed Y, Pfeiffer C, Haj-Yahia S, Alkaiyat A, Tanner M. Understanding the concept and importance of the health research system in Palestine: a qualitative study. Health Res Policy Syst. 2018;16:49. DOI: 10.1186/s12961-018-0315-z

Almeida A.C.G et al. High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon. Parasit Vectors. 2018;11:194. DOI: 10.1186/s13071-018-2787-7

Altiner A.O, Tekeli-Yesil S. Emergency Medical Service (EMS) utilization by Syrian refugees residing in Ankara, Turkey. Prehosp Disaster Med. 2018;33(2):160-164. DOI: 10.1017/S1049023X18000134

Amek N.O et al. Infant and child mortality in relation to malaria transmission in KEMRI/CDC HDSS, Western Kenya: validation of verbal autopsy. Malar J. 2018;17:37. DOI: 10.1186/s12936-018-2184-x